G. Kees HovinghNovo Nordisk AS Copenhagen, Denmark关注立即认领分享关注立即认领分享基本信息浏览量:0职业迁徙个人简介暂无内容研究兴趣论文共 2 篇作者统计合作学者相似作者按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选时间引用量主题期刊级别合作者合作机构ALIROCUMAB TREATMENT IN A REAL WORLD SETTING: SAFETY UPDATE FROM AN OPEN-LABEL TREATMENT EXTENSION TO THE ODYSSEY PROGRAM FOR PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIAJohn Guyton,G. Kees Hovingh,Gisle Langslet,Robert Dufour,Marie Baccara-Dinet, Chantal Din-Bell,Garen Manvelian,Michel FarnierJOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY(2017)引用0浏览0引用00Abstract 16849: Alirocumab Dosing in a Real World Setting: Data From an Open-label Treatment Extension to the ODYSSEY Program for Patients With Heterozygous Familial HypercholesterolemiaG. Kees Hovingh,John R. Guyton,Gisle Langslet,Robert Dufour,Marie T. Baccara-Dinet, Chantal Din-Bell,Garen Manvelian,Michel FarnierCirculation(2016)引用23浏览0引用230作者统计合作学者合作机构D-Core合作者学生导师暂无相似学者,你可以通过学者研究领域进行搜索筛选数据免责声明页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn